Amy L. Burroughs - 28 May 2026 Form 4 Insider Report for Tenaya Therapeutics, Inc. (TNYA)

Reporting relationship: Director
Issuer ticker: TNYA
Reported as of: 28 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 29 May 2026, 19:07:42 UTC
Prior SEC filing: 05 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Jennifer Drimmer Rokovich, Attorney-in-Fact

Key filing fact

Amy L. Burroughs filed Form 4 for Tenaya Therapeutics, Inc. (TNYA) on 29 May 2026.

Key facts

This page summarizes Amy L. Burroughs's Form 4 filing for Tenaya Therapeutics, Inc. (TNYA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 29 May 2026, 19:07.

Change

Previous filing in this sequence was filed on 05 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001872564 Primary reporting owner

Burroughs Amy L.

Relationship: Director
Address: C/O TENAYA THERAPEUTICS, INC., 171 OYSTER POINT BLVD., 5TH FLOOR, SOUTH SAN FRANCISCO
Signature: /s/ Jennifer Drimmer Rokovich, Attorney-in-Fact
Signature date: 29 May 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TNYA transaction Derivative

Stock Option (Right to buy)

Award

Transaction value
Shares: +120,000
Change %
Price: $0.000000^*
Shares after: 120,000
Date: 28 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 120,000
Exercise price: $0.7989
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Option granted pursuant to the Amended and Restated Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full May 28, 2027, or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date.